MondayNov 25, 2024 8:45 am

Kairos Pharma Ltd. (NYSE: KAPA) Developing Innovative Therapies to Tackle Cancer Drug Resistance, Immune Suppression

The company has an extensive IP portfolio, valid through 2040, and a drug pipeline in different preclinical and clinical stages, targeting cancer drug resistance and immune suppression. Kairos Pharma’s lead candidate ENV-105 is an antibody targeting CD105, a protein identified as a key driver of resistance to various cancer treatments. ENV-105 is in a Phase 2 trial for castrate-resistant prostate cancer (NCT05534646, in combination with Apalutamide) and a Phase 1 trial for EGFR-driven non-small cell lung cancer (NCT05401110, in combination with Osimertinib). The company is working with PreCheck Health Services to develop companion biomarkers for ENV-105, with the aim of…

Continue Reading

MondayNov 25, 2024 8:30 am

SuperCom Ltd. (NASDAQ: SPCB) Conference Presentation Focuses on Lives Saved Through EM Technology and Services

SuperCom is an electronic monitoring (“EM”) innovator helping to establish public safety and well-being through the use of advanced technology and monitoring services for government clients that make increasing use of supervised-release programs During a recent investor presentation at the annual LD Micro Invitational, SuperCom’s president and CEO, Ordan Trabelsi, outlined the company’s services and critical benefits to clientele, along with the company’s corresponding success with over 50 governments and 100,000 individuals served SuperCom anticipates that its $32 million contract in Romania, largely focused on monitoring domestic violence offenders, will help boost its credibility with other European governments running monitoring…

Continue Reading

MondayNov 25, 2024 8:25 am

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Share Clinical and Strategic Updates

Annovis Bio (NYSE: ANVS), a clinical-stage company developing therapies for neurodegenerative diseases, will host a live investor webcast on Dec. 11, 2024, at 4:30 PM EST. Led by Founder and CEO Dr. Maria Maccecchini, the event will highlight updates on Phase 3 studies for Parkinson’s and Alzheimer’s diseases, regulatory milestones, financial strategies, and plans for advancing neurodegenerative therapies in 2025. To view the full press release, visit https://ibn.fm/2Ib9D About Annovis Bio Inc. Annovis Bio, headquartered in Malvern, Pennsylvania, is committed to addressing neurodegeneration in diseases such as Alzheimer’s and Parkinson’s. The company is developing innovative therapies that target multiple neurotoxic…

Continue Reading

MondayNov 25, 2024 8:00 am

EXECUTIVE REPORT: 5TH NEXT-GEN MSL EXCELLENCE SUMMIT

Dynamic Global Events recently concluded the 5th Next-Gen MSL Excellence conference, a premier event that brought together MSLs, field medical professionals and industry thought leaders to explore the best ways to grow “soft skills” and maintain productive KOL relationships. This engaging event highlighted innovative strategies, skills development and cutting-edge technologies that are shaping the future of MSLs and their crucial role in bridging scientific knowledge with clinical practice. Key Takeaways from the Conference The conference featured an impressive lineup of speakers, offering invaluable insights on how MSLs can excel in their roles and adapt to industry trends. Leaders from top…

Continue Reading

MondayNov 25, 2024 8:00 am

QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Updates 2024 Exploration Progress at Storm Copper Project, Highlights New Discoveries

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) provided an update on the 2024 exploration activities at the Storm Copper Project on Somerset Island, Nunavut, operated by American West Metals Limited under a 20/80 joint venture agreement. Aston Bay retains a free carried interest until a mining decision is made following a bankable feasibility study. CEO Thomas Ullrich highlighted the discovery of two new zones with copper, zinc, and silver mineralization, emphasizing the potential of the 110 km-long trend. He noted the success of prospecting, geophysics, geochemistry, and drilling efforts and announced ongoing development of a maiden resource and further testing of…

Continue Reading

MondayNov 25, 2024 7:30 am

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Reports Strong Financial Performance and New Contracts, Expanding Footprint in US and Israel

SuperCom (NASDAQ: SPCB) reported a solid performance for Q3 2024, with year-to-date revenue reaching $21.3 million, a 2% increase over the prior year, and gross profit rising 35% to $10.7 million. Strategic contract wins, including a 5-year electronic monitoring project with Israel Prison Service and multiple U.S. contracts in states like West Virginia, Maryland, and New York, underscore SuperCom’s expanding presence in public safety and rehabilitative services. CEO Ordan Trabelsi highlighted SuperCom’s operational efficiency and growth potential, as demonstrated by improved profitability, positive free cash flow, and an increased gross profit margin. The company remains focused on innovation and deepening client…

Continue Reading

FridayNov 22, 2024 3:45 pm

QualityStocksNewsBreaks – Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Capitalizing on Black Sea Area’s Potential

Trillion Energy (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye, is planning strategic growth in the Black Sea area, which has emerged as a critical region for natural-gas exploration and development. “With active projects in the region, particularly in the South Akçakoca Sub-Basin (‘SASB’) off the coast of Türkiye, Trillion Energy is capitalizing on the area’s potential,” reads a recent article. “Trillion Energy has successfully brought several wells in the SASB into production, contributing to the company’s ambitious goal of increasing gas output from the Black Sea. Its current operations have…

Continue Reading

FridayNov 22, 2024 3:00 pm

QualityStocksNewsBreaks – Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR) Leveraging Malartic Package to Meet Demand for Green Metals

Green metals play a pivotal role in promoting sustainability due to their critical use in clean-energy technologies. Renforth Resources (CSE: RFR) (OTCQB: RFHRF) (FSE: 9RR), a Canadian exploration company, was featured in a recent article discussing its positioning to contribute to the green-metals supply through its Quebec-based Malartic Metals Package. “Featuring a 20km-long geological structure hosting nickel, zinc, copper and cobalt — all essential green metals — Renforth’s Victoria polymetallic structure, running across the centre of the Malartic Metals Package, holds significant promise. By exploring and advancing this and several similar occurrences on the property, Renforth is strategically aligning itself…

Continue Reading

FridayNov 22, 2024 1:00 pm

D-Wave Quantum Inc. (NYSE: QBTS) Advances Quantum Computing with Enhanced 4,400+ Qubit Advantage2(TM) Processor

The successful calibration and benchmarking of the 4,400+ qubits Advantage2 processor is a significant milestone in D-Wave’s ongoing development of its sixth-generation annealing quantum computing system. Advantage2 has significantly more computational power than the current Advantage(TM) system, able to solve certain customer problems 25,000 times faster. Advantage2 offers improvements in areas such as faster time-to-solution, higher quality solutions, and ability to solve larger problems. D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, has achieved a significant milestone in the ongoing development of its sixth-generation annealing quantum computing system…

Continue Reading

FridayNov 22, 2024 11:45 am

QualityStocksNewsBreaks – Supreme Court Decision on Meta Platforms Inc. (NASDAQ: META) Lawsuit

The U.S. Supreme Court has opted not to rule on a securities fraud lawsuit against Meta (NASDAQ: META). The lawsuit accuses Facebook, a subsidiary of Meta, of misleading investors about the misuse of user data on its platform. This decision leaves the case unresolved, as the court has chosen to sidestep the issue rather than allowing it to proceed. Meta’s stock price currently stands at $558.10, reflecting a decrease of approximately 0.89% or $4.99. This decline may be influenced by the ongoing legal uncertainties surrounding the company. During the trading day, META’s stock has fluctuated between a low of $556.49…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered